Catalyst Pharmaceutical Partners Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Catalyst Pharmaceutical Partners

CPRX 21.12

+0.7%

11:13 AM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: SteveR who wrote (74)	11/26/1997 2:58:00 PM
From: SirAlexx	Read Replies (1) of 116

more; The following risks are associated with the ownership of Common Stock in the Company. /bullet/ The growth of the Company's business may require additional investment to finance its operations and development. These activities may be financed in whole or in part directly by the Company or its existing or future subsidiaries, through debt or equity financings, or other arrangements. Failure to obtain any required additional financing could adversely affect the growth of the Company. /bullet/ The pharmacy management business is highly competitive. Many actual and potential competitors have greater financial, marketing and other resources than the Company. No assurance can be given that the Company will compete successfully. THE EXCHANGE OFFER Securities to be Exchanged The Exchange Offer is an offer to exchange up to an aggregate of 662,341 shares of Common Stock in exchange for Minority Interests in the Subsidiary, in which the Company owns approximately 92% of the outstanding equity interests. See "Exchange Offer - Securities to be Exchanged." Terms of the Exchange Offer 3.898373 shares of Common Stock will be issued for each one share of Subsidiary Common Stock tendered for exchange. No fractional shares will be issued. Any fractional shares will be rounded (upward) to the nearest whole share. See "Exchange Offer - Terms of the Exchange Offer." Neither holders of equity interests in the Company nor the Subsidiary are required to vote in connection with the Exchange Offer. Because each Minority Holder's participation in the Exchange Offer is voluntary, Minority Holders will not be entitled to exercise any dissenter's or appraisal rights in connection with the Exchange Offer. Purpose and Background of the The Company anticipates achieving Exchange Offer certain benefits from the simplification of its corporate structure, such as (i) enabling the Company to more clearly present its operations to prospective

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next